The magnitude of diabetes mellitus (DM) has increased in recent decades, where the
number of cases and the proportion of the disease have been gradually increasing over the …

Aim Dyslipidemia is an established marker for endothelial dysfunction and cardiovascular
risk in diabetes. So we aimed to explore the prevalence of dyslipidemia in patients with …

Background and aims Despite the relation between autoimmune diseases and increased
atherosclerotic risk is established, the influence of autoimmune disorders on in-stent …

Background There is limited information about cardiovascular complications among young
adults (YA) with type 1 diabetes mellitus (T1DM) who are transitioning from pediatric to adult …

Background Hyperglycemia and dyslipidemia are commonly found metabolic abnormalities
in diabetic children and adolescents and both increase the risk of cardiovascular disease …

Although B lymphocytes are a key cell type that drives type 1 diabetes (T1D), therapeutic
targeting of these cells has not ameliorated disease, and it has been impossible to eliminate …

Background Hyperlipidaemia may play a significant role in the interrelationship between
type 1 diabetes (T1D) and periodontal disease. A potential mechanism that links these three …

Background: Vitamin D (VD) was suggested to have both direct and indirect effects on
modifying lipid profile in patients with diabetes through its regulatory action that increases …

Background Dyslipidemias are disorders of lipoprotein metabolism that occur during
childhood and adolescence, often persist into adulthood, and increase the risk of developing …

Background: Diabetic dyslipidemia has specifics that differ from dyslipidemia in patients
without diabetes, which contributes to accelerated atherosclerosis equally as dysglycemia …